Intra-action review (IAR)

Conducting an IAR during a emergency or a humanitarian crisis is crucial for facilitating real-time course correction, fostering immediate, and sustained learning and improvement within the response systems, allowing countries to continually assess and adapt their strategies. This country-led process enables stakeholders to evaluate the functional capacities of public health and emergency response systems at national or subnational levels during a health emergency or a humanitarian crisis. The aim is to identify best practices, challenges, lessons learned, and propose real-time corrective measures for immediate action or sustained improvement in the outbreak response.

 

 

Key Publication

IAR LOGO

Guidance for Conducting a Country COVID-19 Intra-Action Review (IAR)

The WHO Guidance for Conducting a Country COVID-19 Intra-Action Review (IAR) was developed to guide countries to conduct periodic review(s) of their national and subnational COVID-19 response, so countries do not miss critical opportunities for learning and improvement to better respond to the COVID-19 outbreak in their countries. The IAR is a country-led facilitated process conducted during the COVID-19 outbreak in-country, bringing together a small group of COVID-19 responders with knowledge of the public health response pillars under review. Although IARs can be conducted online or face-to-face, the online format is recommended, especially if community transmission remains high in the country. The IAR will identify practical areas for immediate remediation and sustained improvement of the ongoing response.

1 June 2026

Psychological self-help interventions: delivering self-help for individuals, featuring Step-by-Step and Doing What Matters in Times of Stress: web annex: Step-by-Step: a self-help intervention for depression

1 June 2026

Psychological self-help interventions: delivering self-help for individuals, featuring Step-by-Step and Doing What Matters in Times of Stress

29 May 2026

Pesticide residues in food: report 2025: Joint FAO/WHO Meeting on Pesticide Residues

29 May 2026

Meeting of the Strategic Advisory Group of Experts on Immunization, March 2026: conclusions and recommendations

28 May 2026

WHO Technical Advisory Group on therapeutics prioritization for Bundibugyo virus disease: meeting report, 20 and 26 May 2026

28 May 2026

WHO Technical Advisory Group on candidate vaccine prioritization: meeting report, 19 and 25 May 2026

28 May 2026

WHO emergency guidance on the use of licensed Ebola virus vaccine during Bundibugyo virus disease outbreaks, 28 May 2026

28 May 2026

Guidelines for the prevention of bloodstream infections and other infections associated with the use of intravascular catheters: part 2: central venous catheters

28 May 2026

WHO guidance for mass gathering events attended by individuals from areas with documented Bundibugyo virus detection, May 2026

26 May 2026

WHO practical manual on meningitis diagnosis, treatment and care

26 May 2026

Implementation of border health and international travel-related temporary recommendations issued by the Director-General of WHO to States Parties not sharing land borders with areas with documented Bundibugyo virus detection

26 May 2026

Evaluation of Global Health Days 2019-2023: Report

26 May 2026

Contingency fund for emergencies: 2025 annual report

20 May 2026

Group Problem Management Plus (PM+) psychological intervention: training manual

20 May 2026

Ensuring Quality in Psychosocial and Mental Health Care (EQUIP): compendium of competency assessment tools

17 May 2026

Infection prevention and control guideline for Ebola and Marburg diseases

15 May 2026

Laboratory testing of Andes virus (Orthohantavirus andesense) infection: interim guidance, 15 May 2026

15 May 2026

Dracunculiasis eradication: global surveillance summary, 2025

15 May 2026

Exposing marketing tactics and strategies driving the global growth of nicotine pouches

15 May 2026

Measuring integrated delivery of essential public health functions: a review of health systems and health security monitoring tools

COVID-19 IAR Online Training

Global Analysis of COVID-19 IARs

WHO Press Conference

Overview: The Country COVID-19 Intra-Action Review (IAR) is a facilitated process that brings together COVID-19 responders from multiple sectors for experience sharing and collective learning, and it has been modelled after the WHO After Action Review (AAR) methodology. This course provides a general introduction to the management and the facilitation of an IAR during the ongoing COVID-19 pandemic through presentations, quizzes and an assessment at the end of the course to test the knowledge acquired. It targets any individuals or entities involved in the preparedness of and response to the COVID-19 outbreak at the national or subnational levels, including but not limited to Government officials, WHO staff, public health professionals, communities and partners.

In line with the advice and temporary recommendations from the 4th, 5th, 11th and 12th IHR (2005) Emergency Committee on COVID-19, a global analysis of IAR reports received by WHO in collaboration with all six WHO regional offices and country offices has been conducted. A total of 83 reports from 57 countries comprising 2556 best practices, 2366 challenges, and 2859 recommendations were analyzed and triangulated with 27 interviews and 29 survey consultations with countries. This global analysis took a solution-oriented angle aimed at consolidating and showcasing the various strategies adopted by countries to address and overcome common challenges to the COVID-19 response, and to bring these learning to the rest of the world to encourage peer learning. 

COVID-19 vaccination IAR

As countries conduct mini COVID-19 vaccine Post-Introduction Evaluation (mini-cPIE), also called the COVID-19 Vaccination Intra-Action Review (IAR), to review and adjust their COVID-19 vaccine roll-out, WHO will be hosting regular clinics for countries to share learnings with peer countries.